Cold Plasma and Pacemakers: Safety Insights

Cold Plasma With Pacemakers or Implants

Cold plasma therapy is a growing area of plasma medical applications, especially in wound care, dermatology, and surgical tissue treatment. For people with a pacemaker, implantable cardioverter-defibrillator, neurostimulator, or another electronic implant, the key issue is not simply whether the plasma feels “cold,” but whether the specific device creates electrical, magnetic, radiofrequency, or high-voltage effects close enough to affect the implant. This guide explains the practical safety questions to ask before treatment, how clinicians think about risk, and why individualized medical clearance matters.

Can you use cold plasma therapy if you have a pacemaker or implant?

Sometimes, but it should not be treated as automatically safe. A person with a pacemaker or other active implant should tell the treating clinician before any cold plasma therapy, and the clinician should review the plasma device’s labeling, the treatment location, and the implant manufacturer’s precautions before proceeding. The safest answer is device-specific: a low-power surface wound-care device used far from the chest is a different situation from a helium-based electrosurgical plasma ablation system used in an operating room.

Pacemakers and ICDs are designed to work in everyday environments, but they can still be affected by electromagnetic interference, strong magnets, and certain medical procedures. Cardiology guidance notes that electromagnetic waves from some devices can interfere with pacemakers and ICDs.

That does not mean every plasma treatment is unsafe. It means “cold plasma” is too broad a phrase to use as the only basis for a decision. Cold atmospheric plasma used for wound care, low-power plasma pens for skin lesion destruction, and electrosurgical plasma ablation systems can differ in energy delivery, distance from tissue, waveform, voltage, grounding, accessories, and intended use.

Cold plasma, in plain language

Cold plasma, often called cold atmospheric plasma or non-thermal plasma, is an ionized gas containing charged particles, reactive oxygen and nitrogen species, photons, and electric fields. “Cold” means the treatment is designed to limit heat transfer to tissue compared with traditional thermal cautery or hot plasma systems; it does not mean the treatment is biologically inactive or electrically irrelevant. The same properties that make plasma interesting for medicine are also why implant safety deserves careful screening.

In clinical and research settings, cold plasma therapy is most often discussed for wound care, microbial reduction, dermatologic procedures, and surgical tissue applications. Reviews of plasma medical applications describe potential value in wound healing and infection control, particularly because cold atmospheric plasma may offer a non-antibiotic approach to reducing microbial burden.

Cold plasma can be delivered in different ways. Some systems generate a plasma jet using a gas such as helium or argon. Others create a discharge between an electrode and the skin, and some are integrated into electrosurgical platforms. These technical differences matter because an implant does not “see” a marketing category; it responds, if at all, to electrical current paths, electromagnetic emissions, magnetic fields, and proximity.

Why can cold plasma matter for implanted devices?

Cold plasma can matter for implanted devices because many plasma systems use electrical energy to create and sustain the plasma. If that energy produces electromagnetic interference or allows current to travel through the body near an implant or its leads, a pacemaker, ICD, or other active implant may misinterpret signals or temporarily change behavior. The concern is usually not the word “plasma” itself; it is the energy source, treatment site, device design, and patient dependence on the implant.

For pacemakers, electromagnetic interference can be sensed as if it were the heart’s own electrical activity. In some circumstances, that can lead to oversensing and inappropriate inhibition of pacing. For ICDs, interference can potentially be interpreted as an abnormal rhythm, which may lead to inappropriate therapy if precautions are not used. A cardiology scientific statement on cardiovascular implantable electronic devices describes electrosurgery-related risks including pacemaker oversensing or inhibition and inappropriate ICD therapy.

This is especially relevant because some plasma technologies overlap with electrosurgery. The same statement notes that endoscopic argon plasma coagulation uses monopolar circuitry and high voltage and is more likely to result in electromagnetic interference.

The practical takeaway is simple: a patient should not assume that “non-thermal” means “no implant issue.” Temperature and electromagnetic compatibility are different safety questions.

Active implants deserve a higher level of screening

Implants fall into two broad categories: passive and active. Passive implants include items such as many orthopedic plates, screws, joint replacements, dental implants, and some vascular clips. These do not sense heart rhythm or deliver electrical therapy. Active implants include pacemakers, ICDs, cardiac resynchronization therapy devices, implantable loop recorders, deep brain stimulators, spinal cord stimulators, cochlear implants, implantable drug pumps, and some newer neuromodulation systems.

Active implants require the most caution because they contain electronics, leads, sensors, batteries, or programmed therapy settings. Modern pacemaker technology has advanced considerably, and many devices are engineered with electromagnetic compatibility in mind. However, pacemaker advancements do not remove the need for procedure-specific precautions, because the risk depends on the external energy source and the individual’s medical condition.

Common implant considerations before plasma treatment:

• Pacemaker or cardiac resynchronization pacemaker: Could be affected if electrical noise is sensed as cardiac activity, especially if the patient is pacing-dependent.

• ICD or CRT-D: Requires added caution because inappropriate shock therapy is a possible concern with electromagnetic interference.

• Leadless pacemaker: May have different manufacturer instructions than a traditional transvenous system, so the implant model matters.

• Implantable loop recorder: Usually diagnostic rather than therapeutic, but interference can affect recorded data.

• Neurostimulator or cochlear implant: May be sensitive to energy sources near the device, leads, or receiver.

• Passive metal implant: Often less concerning for electromagnetic sensing, but the treatment team should still consider heating, current paths, and local tissue effects.

Patients should bring their implant identification card to any consultation. That card typically gives the model, manufacturer, implant date, and clinician contact information, which allows the treating team to check the correct precautions instead of guessing.

Cold plasma devices are not all the same

The phrase “cold plasma treatment benefits” often appears in patient education and marketing, but it can flatten important distinctions between devices. A wound-care plasma device, a dermatology plasma pen, and an operating-room plasma ablation platform may all involve plasma, yet their clinical purpose and energy profile can be very different. Safety decisions should be tied to the exact device being used.

Low-temperature plasma for wound care is generally discussed as an adjunct to standard wound care, not as a replacement for debridement, compression, offloading, infection management, vascular assessment, or glucose control when those are needed. Systematic reviews have evaluated cold atmospheric plasma for chronic wounds and bacterial reduction, but the strength of evidence varies by wound type, study design, and device.

Dermatology plasma devices may use a small electrical arc near the skin to create controlled tissue effects.

Surgical cold plasma systems can involve gas-enhanced tissue ablation or coagulation in controlled procedural environments. These settings may allow monitoring, device interrogation, reprogramming, magnet protocols, and emergency support when indicated. That is very different from a spa, salon, or unsupervised home-use environment.

A practical risk framework for patients and clinicians

No single checklist can replace medical judgment, but a structured review helps identify the issues that matter most. The treatment team should consider the implant, the plasma system, the treatment site, and the patient’s dependence on the implanted therapy.

Key questions to answer before treatment:

• What implant does the patient have? Identify whether it is a pacemaker, ICD, CRT device, neurostimulator, cochlear implant, drug pump, passive metal implant, or another device.

• Is the patient dependent on the implant? A pacing-dependent patient faces different consequences from temporary interference than a patient who rarely requires pacing.

• Where will plasma be applied? Treatment on the chest, shoulder, neck, upper back, or near a device pocket deserves more caution than treatment far from the implant.

• What type of plasma device is being used? Confirm whether it is a wound-care device, dermatologic plasma pen, electrosurgical ablation system, or another category.

• Does the device labeling mention implanted electronic devices? The user manual and contraindications are more important than general claims about cold plasma therapy.

• Will current pass through the body? Monopolar electrosurgical systems and grounding arrangements require careful planning in patients with cardiac devices.

• Can the implant be checked before and after? For higher-risk procedures, device interrogation may help confirm baseline function and post-procedure status.

• Is the setting equipped for monitoring? Procedures near active implants may require ECG monitoring, external defibrillation capability, and personnel who understand CIED precautions.

This framework also helps patients ask clear questions. Instead of asking only, “Is cold plasma safe with my pacemaker?” ask, “Has this specific plasma device been reviewed for use in people with my exact implant, at this treatment location, with my cardiology team’s input?”

What should patients do before cold plasma therapy?

Patients should disclose every implant, share their implant card, and ask the treating clinician to coordinate with the implant-managing specialist when the treatment involves electrical energy, the upper body, or any uncertainty. They should not rely on a brief reassurance from a nonmedical provider if they have a pacemaker, ICD, neurostimulator, or other active implant. The goal is not to create fear; it is to make sure the right precautions are used before treatment begins.

Cardiology guidance advises people with pacemakers to tell doctors, dentists, nurses, medical technicians, and other healthcare professionals that they have a pacemaker. That principle applies well to cold plasma therapy because the provider may not otherwise know that an implanted electronic device is present.

Patient preparation checklist:

• Bring your implant ID card and the name of the clinician who manages the device.

• Ask for the exact name and model of the cold plasma device being used.

• Ask whether the device is considered electrosurgical, radiofrequency, high-voltage, or monopolar.

• Confirm whether the manufacturer lists pacemakers, ICDs, or implanted electronic devices in warnings or contraindications.

• Tell the provider if you have ever been told you are pacing-dependent.

• Avoid treatment directly over or near the implant unless a qualified clinician has specifically cleared it.

• For cosmetic or wellness services, request written medical clearance before scheduling.

• If you feel dizziness, palpitations, shocks, chest discomfort, or unusual symptoms during or after treatment, stop and seek medical help.

Patients should also be cautious with claims that sound absolute, such as “safe for everyone,” “no electricity enters the body,” or “no risk with pacemakers.” A responsible provider should be willing to pause, check documentation, and involve the appropriate specialist.

Clinical precautions that may be considered

Clinicians typically base precautions on the implant type, the procedure location, and whether the procedure could generate electromagnetic interference. For cardiovascular implantable electronic devices, periprocedural planning may include determining pacing dependence, reviewing the device type, considering ICD therapy suspension when appropriate, choosing energy settings carefully, and monitoring the patient. The cardiology scientific statement emphasizes multidisciplinary care pathways for patients with cardiac implantable electronic devices.

In practical terms, precautions may include using the lowest effective energy, keeping the active treatment field away from the implant generator and leads, positioning any return electrode to keep current paths away from the device, and limiting bursts of energy when applicable. For procedures with meaningful EMI risk, the implant team may recommend interrogation before and after treatment or temporary programming changes.

These decisions should be made by qualified clinicians. A cosmetic provider, wound-care clinician, dermatologist, surgeon, cardiologist, electrophysiologist, or device representative may each have part of the picture. The safest pathway is collaborative, especially when the treatment site is above the umbilicus, near the implant pocket, or near leads.

Plasma treatment benefits must be weighed against alternatives

Cold plasma therapy may offer useful benefits in selected settings, particularly as an adjunct approach in wound care or tissue management. Research reviews discuss antimicrobial effects, wound-healing mechanisms, and potential roles in chronic wounds, including diabetic foot ulcers and other difficult wounds.

For a patient with a pacemaker or implant, the question is not only “Does plasma work?” It is “Does this specific benefit justify this specific risk when safer or better-established alternatives may exist?” For example, a chronic wound may also need pressure relief, vascular evaluation, infection treatment, nutrition support, edema control, or standard dressings. A cosmetic skin concern may have non-energy-based options that avoid implant uncertainty.

A balanced discussion should include:

• the expected purpose of plasma treatment;

• the seriousness of the condition being treated;

• other reasonable treatment options;

• the distance from the implant;

• the patient’s dependence on the implant;

• the available monitoring and emergency support;

• the quality of evidence for that use;

• and the device manufacturer’s implant-related warnings.

This is where good medical decision-making becomes personal. A hospital-based procedure to manage a serious surgical problem may justify precautions that would not be appropriate for an elective cosmetic service.

Pacemaker technology keeps improving, but caution still matters

Pacemaker advancements have made modern devices more sophisticated than older systems. Many can store diagnostic information, communicate wirelessly with programmers or remote monitoring platforms, and use algorithms to adapt pacing to a patient’s needs. Some devices are MRI-conditional under strict conditions, and leadless pacemakers have changed the design of pacing systems for selected patients.

Even with these advances, electromagnetic compatibility remains a real design and safety consideration.

The nuance is important: better pacemaker technology does not mean every energy-based treatment is automatically safe. It means clinicians have more information, better device diagnostics, and more structured pathways for managing risk. Patients benefit most when those tools are actually used.

Red flags that should stop or delay treatment

Some situations call for a pause until the implant-managing clinician or device manufacturer can be consulted. This is especially true outside medical settings, where monitoring and emergency support may be limited.

Stop-and-check situations:

• The provider does not ask about pacemakers, ICDs, or implants before treatment.

• The plasma device manual is unavailable or the provider has not reviewed contraindications.

• Treatment would be applied over the chest, upper back, neck, shoulder, or directly near an implant.

• The patient has an ICD and no plan exists for managing possible interference.

• The patient is pacing-dependent or does not know whether they are.

• The device is described as electrosurgical, high-voltage, monopolar, or arc-producing, but no implant precautions are planned.

• The setting cannot monitor symptoms or respond to an urgent cardiac event.

• The provider makes broad safety promises without checking the implant model.

These red flags do not always mean treatment is impossible. They mean the decision is not ready yet.

Questions to ask your cardiology or implant team

A short, specific message to the implant team is usually more useful than a vague request. Patients can say: “I am considering cold plasma therapy using this device, on this body area, for this condition. I have this implant model. Are there precautions, contraindications, or monitoring steps I need?”

Helpful questions include:

• Is my device a pacemaker, ICD, CRT-P, CRT-D, loop recorder, or another type?

• Am I pacing-dependent?

• Are there restrictions for electrosurgery, radiofrequency, or high-voltage skin devices?

• Is treatment near my implant pocket or leads a concern?

• Do I need device interrogation before or after the procedure?

• Should any device settings be changed temporarily?

• Should the procedure be done only in a monitored medical setting?

This approach gives the specialist enough context to provide meaningful advice. It also creates a record that the implant was considered before treatment.

The bottom line for safe decision-making

Cold plasma therapy has promising and established medical uses in selected contexts, but patients with pacemakers or implants need individualized screening. The most important safety factors are the implant type, whether it is active or passive, the plasma device’s energy profile, the treatment location, and the clinical setting. A cautious review is especially important for pacemakers, ICDs, CRT devices, neurostimulators, cochlear implants, and any implanted system that senses or delivers electrical signals.

If you have an implant, do not assume cold plasma therapy is either completely forbidden or automatically safe. Bring your implant card, ask for the exact plasma device information, and involve the clinician who manages your implant before treatment. Used thoughtfully, plasma medical applications can be evaluated on their real merits while protecting the implanted technology that may be essential to your health.

Ready to offer cold plasma treatments your clients will love? Explore the Wikbeauty Cold Plasma Machine and find the right system for your spa or home. Shop now at wikbeauty.com, or contact our team for expert advice and a quote today.

Explore Product: Cold Plasma Machine